CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors

AIM: To test radiomic approach in patients with metastatic neuroendocrine tumors (NETs) treated with Everolimus, with the aim to predict progression-free survival (PFS) and death. MATERIALS AND METHODS: Twenty-five patients with metastatic neuroendocrine tumors, 15/25 pancreatic (60%), 9/25 ileal (3...

Descripción completa

Detalles Bibliográficos
Autores principales: Caruso, Damiano, Polici, Michela, Rinzivillo, Maria, Zerunian, Marta, Nacci, Ilaria, Marasco, Matteo, Magi, Ludovica, Tarallo, Mariarita, Gargiulo, Simona, Iannicelli, Elsa, Annibale, Bruno, Laghi, Andrea, Panzuto, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Abdominal Radiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308597/
https://www.ncbi.nlm.nih.gov/pubmed/35717429
http://dx.doi.org/10.1007/s11547-022-01506-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308597/
https://www.ncbi.nlm.nih.gov/pubmed/35717429
http://dx.doi.org/10.1007/s11547-022-01506-4

Ejemplares similares